Prepared by the PIP Action Campaign (survivor-led advocacy). This page is information, not individual medical advice.
Information for Women with PIP Breast Implants
Updated guidance prepared by the PIP Action Campaign (survivor-led advocacy), 2025.
1) What PIP implants are
Poly Implant Prothèse (PIP) implants were silicone breast implants manufactured in France until 2010. Investigations confirmed the company used industrial-grade silicone instead of approved medical-grade gel. Production and use were halted after fraud was uncovered in 2010.
2) Who may have been affected (UK)
About 47,000 women in the UK received PIP implants before March 2010, in both private clinics and some NHS breast reconstructions. Because the UK’s earlier registry closed in 2006, many women were not traceable when the scandal emerged.
3) Key safety issues
- Higher rupture/leak rate than other implants.
- Toxic gel composition: low-molecular-weight siloxanes (D4–D6) and other contaminants can migrate to tissue and lymph nodes.
- Inflammation and pain from silicone leakage or “bleed”.
- Implant-associated cancers: BIA-ALCL (lymphoma) and BIA-SCC (very rare) are now recognised by regulators. Late-onset swelling/fluid around the implant must always be investigated.
🚩 Red-flag symptoms – seek medical advice promptly
- New or progressive swelling of the breast or underarm
- Fluid collection (seroma) or a palpable mass/lump
- Changes in shape, persistent pain, redness, or warmth
- Systemic symptoms that persist (fatigue, rashes, joint pains) with no other explanation
Ask for ultrasound ± MRI and cytology of any fluid. Keep copies of all reports.
4) If you still have PIP implants – what to do
- Book a clinical review via your GP or surgeon; imaging (ultrasound/MRI) may be recommended.
- Discuss removal (explant) if there is rupture, fluid, pain, inflammation or significant concern.
- Remove implant and capsule together when indicated. The capsule can contain silicone and pathological changes and should be sent for pathology.
- Keep records (operation notes, implant stickers, imaging, pathology) and report problems via the MHRA Yellow Card scheme.
NHS access: The NHS removes PIP implants fitted by the NHS and may remove privately fitted implants if the clinic has closed and care cannot be obtained. Our campaign advocates full NHS support for removal in all PIP cases due to the product’s criminal origin.
More about complete removal (implant + capsule)
Safe removal of a PIP implant usually means removing both the implant and the surrounding capsule (the fibrous tissue that forms around it). The capsule may hold leaked silicone, inflammatory changes, or early disease, so leaving it behind can pose ongoing risks. Read our full briefing below for medical reasons and questions to ask your surgeon.
See Complete Removal of PIP Implants and Capsules below
5) Pregnancy, breastfeeding and children
PIP gels contained volatile siloxanes (D4–D6). Human data are limited; a precautionary approach is appropriate if you were pregnant or breastfeeding while PIP implants were in place. Keep records for children potentially exposed in utero or via breast milk and discuss follow-up with your GP.
6) Monitoring and long-term health
- Lifelong awareness of symptoms and changes in the breast.
- Late-onset swelling (> 1 year after surgery) warrants ultrasound and cytology.
- Maintain a personal file of all results and letters.
7) Your rights and redress
- Recognition as a victim of product fraud.
- Access to free removal and after-care, with pathology of capsule/fluid.
- Inclusion in any Public Inquiry and future redress scheme.
- Right to disclosure of safety data under the Duty of Candour.
© 2025 PIP Action Campaign. Last updated October 2025. Plain HTML for fast loading and accessibility.
Complete Removal of PIP Implants and Capsules – Briefing (2025)
1) Why the capsule matters
Every breast implant develops a fibrous capsule around it. With PIP implants, this capsule often contains leaked silicone droplets, low‑molecular‑weight siloxanes (D4–D6), and chronic inflammatory changes. Rare implant‑associated cancers (BIA‑ALCL, BIA‑SCC) arise in the capsule and periprosthetic fluid rather than the implant shell itself.
2) When complete removal is indicated
- Confirmed or suspected rupture/leak, persistent pain, swelling, or inflammation.
- Periprosthetic fluid (seroma) present, especially late‑onset swelling (> 1 year post‑op).
- Recurrent symptoms after prior implant‑only removal; or strong patient preference after risk discussion.
Red flags: new swelling, seroma, a mass, skin changes, or systemic symptoms. Ask for ultrasound ± MRI and cytology of fluid.
3) Surgical approach
- Total (en‑bloc) capsulectomy – implant and capsule removed together where safe and feasible.
- Total capsulectomy – entire capsule removed (piecemeal) when en‑bloc is not possible.
- Avoid leaving capsule remnants when there is rupture, fluid, or chronic inflammation.
4) Pathology & evidence preservation
- Send capsule and any fluid for histology/cytology (including CD30 immunostaining when indicated).
- Request a copy of the pathology report and ask your surgeon to retain representative samples.
- Keep implant stickers/UDI, photos, and operative notes with your records.
5) Risks, recovery, and reconstruction
- Discuss surgical risks (bleeding, infection, contour changes) and the plan for drains and pain control.
- Reconstruction options: lift, fat transfer, or delayed re‑implantation after full recovery and risk review.
- Some women feel better after complete removal; others may need further care. Record symptoms before/after.
6) NHS access & policy
The campaign recommends that the NHS fund complete removal (implant plus capsule) for all women with PIP implants, with standardised pathology testing, regardless of where the original surgery occurred. This reflects the criminal origin and higher rupture/toxicity profile of PIP devices.
7) Questions to ask your surgeon
- Will you remove the entire capsule (en‑bloc if safe)? If not, why?
- How will you handle and test any fluid and capsule tissue?
- What is the plan for pain control, drains, and follow‑up imaging?
- Can I have copies of the operative report, implant IDs, and pathology results?
Prepared by the ©PIP Action Campaign (survivor-led advocacy). This page is information, not individual medical advice.
